Analysts Upgrades – AMED, RGS, MYRG
The following stocks have recently had their ratings upgraded by stock analysts.
Amedisys (AMED)
Deutsche Bank has upgraded Amedisys’s rating
from: Hold – to – Buy
Target Price: $39.00
Regis (RGS)
Wedbush has upgraded Regis’s rating
from: Neutral – to – Outperform
Target Price: $22.00
MYR Group (MYRG)
Wedbush has upgraded MYR Group’s rating
from: Neutral – to – Outperform
Target Price: $26.00